Cargando…
A potential new approach for treating systemic sclerosis: Dedifferentiation of SSc fibroblasts and change in the microenvironment by blocking store-operated Ca(2+) entry
Transforming growth factor-β (TGF-β) is an important target for treating systemic sclerosis (SSc). However, our study revealed three levels of TGF-β1 expression in SSc patients, indicating that inhibiting TGF-β is not sufficient to treat SSc. A previous clinical trial also displayed disappointing re...
Autores principales: | Wu, Ching-Ying, Hsu, Wen-Li, Tsai, Ming-Hsien, Chai, Chee-Yin, Yen, Chia-Jung, Chen, Chu-Huang, Lu, Jian-He, Yu, Hsin-Su, Yoshioka, Tohru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417669/ https://www.ncbi.nlm.nih.gov/pubmed/30870448 http://dx.doi.org/10.1371/journal.pone.0213400 |
Ejemplares similares
-
Regulation of Store-Operated Ca(2+) Entry by Septins
por: Deb, Bipan K., et al.
Publicado: (2016) -
Regulation of Store-Operated Ca(2+) Entry by SARAF
por: Dagan, Inbal, et al.
Publicado: (2021) -
Store-operated Ca(2+) entry in muscle physiology and diseases
por: Pan, Zui, et al.
Publicado: (2014) -
Role of store-operated Ca2+ entry in cardiovascular disease
por: Lu, Ting, et al.
Publicado: (2022) -
Lysosomal agents inhibit store-operated Ca(2+) entry
por: Morgan, Anthony J., et al.
Publicado: (2021)